Toll-like receptor (TLR)3 is a key component of the innate immune response to viral infection. The present study firstly examined whether sex differences exist in TLR3-induced inflammatory, endocrine, and sickness responses. The data revealed that TLR3-induced expression of interferon-or NFkB-inducible genes (IFN-a/b, IP-10, or TNF-a), either peripherally (spleen) or centrally (hypothalamus), did not differ between male and female rats, with the exception of TLR3-induced IFN-a expression in the spleen of female, but not male, rats 8 hr post TLR3 activation. Furthermore, TLR3 activation increased plasma corticosterone levels, induced fever, and reduced locomotor activity and body weight -effects independent of sex. Thus, the acute-phase inflammatory, endocrine, and sickness responses to TLR3 activation exhibit minimal sex-related differences. A further aim of this study was to examine whether enhancing endocannabinoid tone -namely, 2-arachidonylglycerol (2-AG) or N-arachidonoylethanolamine (AEA), exhibited similar effects on TLR3-induced inflammatory responses in male versus female rats. Systemic administration of the monoacylglycerol lipase (MAGL) inhibitor MJN110 and subsequent increases in 2-AG levels did not alter the TLR3-induced increase in IP-10, IRF7, or TNF-a expression in the spleen or the hypothalamus of male or female rats. In contrast, the fatty acid amide hydrolase (FAAH) inhibitor URB597 increased levels of AEA and related N-acylethanolamines, an effect associated with the attenuation of TLR3-induced inflammatory responses in the hypothalamus, but not the spleen, of male and female rats. These data support a role for FAAH, but not MAGL, substrates in the modulation of TLR3-induced neuroinflammatory responses, effects independent of sex. 
susceptibility (Costello & Lynch, 2013; Galic, Riazi, Henderson, Tsutsui, & Pittman, 2009) , impaired contextual and working memory (Galic et al., 2009) , anxiety-and depressive-like behavior (Gibney, McGuinness, Prendergast, Harkin, & Connor, 2013) , and exacerbation of underlying neurodegenerative processes (Field, Campion, Warren, Murray, & Cunningham, 2010) . Thus, regulation of TLR3-associated inflammation is of both physiological and potentially therapeutic significance. Sex-related differences in inflammation, neural functioning, and behavior are increasingly being recognized (Nelson & Lenz, 2017; Rosen, Ham, & Mogil, 2017; Tronson & Collette, 2017) and have highlighted that data obtained in one sex are not always applicable to both (see special issue [Cahill, 2017] ). Sex differences have been reported in the manifestation of, and susceptibility to, bacterial and viral infection (Klein & Flanagan, 2016; Marriott & Huet-Hudson, 2006) ; however, sex-related differences in TLR-induced inflammatory responses have not been widely studied. Clinical studies have demonstrated that the stimulation of peripheral blood mononuclear cells (PBMCs) and plasmacytoid dendritic cells (pDCs) by TLR7 ligands results in greater type 1 interferon (IFN)-a production in cells derived from women (Berghofer et al., 2006; Meier et al., 2009; Torcia et al., 2012) while men produced greater amounts of the immunosuppressive cytokine interleukin (IL)-10 in response to TLR8 and TLR9 activation (Torcia et al., 2012) . Furthermore, lipopolysaccharide-induced TLR4 activation and subsequent production of proinflammatory cytokines from peripheral blood cells differ between men and women (Aomatsu, Kato, Kasahara, & Kitagawa, 2013; Asai et al., 2001; Aulock et al., 2006; Imahara, Jelacic, Junker, & O'Keefe, 2005; Lefèvre, Corazza, Duchateau, Desir, & Casimir, 2012; Moxley et al., 2004) . Increased levels of peripheral proinflammatory cytokines communicate with the brain, resulting in neuroinflammatory responses, leading to fever, hypothalamic-pituitary-adrenal (HPA) axis activation, and behavioral alterations such as hypolocomotion and anorexia-collectively referred to as "sickness behavior" (Dantzer, 2001 (Dantzer, , 2009 ). Several aspects of TLR4-induced sickness behavior differ between males and females, including a sex-specific reduction in food intake and a greater fever response in male rats (Ashdown, Poole, Boksa, & Luheshi, 2007; Avitsur, Weidenfeld, & Yirmiya, 1999; Cai et al., 2016; Pitychoutis, Nakamura, Tsonis, & Papadopoulou-Daifoti, 2009 ). However, whether such effects are also observed in relation to activation of other TLRs is unknown. Systemic administration of the viral mimetic and TLR3 agonist polyinosinic-polycytidylic acid (poly I: C) increases the expression of type 1 IFNs (IFN-a and IFN-b) and NFOEB-inducible cytokines (e.g., IL-1b, IL-6, TNF-a) in the periphery and in the brain as part of the antiviral response, including the hypothalamus, which is a key brain region mediating sickness behavior (Cunningham, Campion, Teeling, Felton, & Perry, 2007; Fortier et al., 2004; Henry, Kerr, Finn, & Roche, 2014; Konat, Borysiewicz, Fil, & James, 2009) . However, studies examining the effects of poly I:C are conducted interchangeably between males (Fortier et al., 2004; Gibney et al., 2013; McLinden et al., 2012) and females (Cunningham et al., 2007; Murray et al., 2015) or a mixture of males and females (Costello & Lynch, 2013) , with potential sex differences unexplored.
Therefore, the first aim of the current study was to examine potential sex differences in acute TLR3-induced inflammatory, endocrine, and sickness responses.
The endocannabinoid system has been shown to exhibit potent immunomodulatory effects and represents a potential therapeutic target for peripheral and central inflammatory disorders (Burke, Finn, & Roche, 2015; Cabral, Rogers, & Lichtman, 2015; Downer, 2011; Fitzgibbon, Finn, & Roche, 2016; Witkamp, 2016) . The best-characterized endocannabinoids are Narachidonoylethanolamine (AEA) and 2-arachidonylglycerol (2-AG) (Devane et al., 1992; Mechoulam et al., 1995; Sugiura et al., 1995) . The main enzyme for the degradation of AEA and related fatty acid amides, N-oleoylethanolamide (OEA) and N-palmitoylethanolamide (PEA), is fatty acid amide hydrolase (FAAH) (Cravatt et al., 1996) , while 2-AG is hydrolyzed primarily by monoacylglycerol lipase (MAGL) (Dinh et al., 2002) . Both in vitro and in vivo studies have demonstrated that enhancing endocannabinoid tone modulates inflammatory mediators following TLR4 activation (for detailed review, see Henry et al., 2016 ).
For example, recent studies from our group have demonstrated that inhibition of FAAH and subsequent increases in AEA levels result in an attenuation of TLR4-induced proinflammatory cytokine responses in several brain regions, including the hypothalamus (Henry et al., 2017; Kerr et al., 2012) . Furthermore, FAAH substrates, including AEA, have been demonstrated to modulate TLR4-induced temperature changes and hypophagia (Hollis, Jonaidi, Lemus, & Oldfield, 2011; Sayd et al., 2014; Steiner et al., 2011) . Collectively, this demonstrates a role for FAAH substrates in the modulation of neuroinflammatory responses following TLR4 activation. However, there is a lack of studies investigating the effects of endocannabinoid modulation of inflammatory responses to other TLRs, such as TLR3. The potent synthetic cannabinoid (CB) agonist WIN55,212-2 has been shown to augment IRF3 signaling and IFN-b production while concurrently attenuating TLR3-induced nuclear factor kappa B (NFjB) activation and subsequent increases in TNF-a in astrocyte cultures . Recent in vivo work from our group has demonstrated that the systemic and central administration of the FAAH inhibitor URB597 was associated with the modulation of TLR3-induced neuroinflammatory responses in the hippocampus (Henry et al., 2014) . However, to date, there have been no studies examining whether increasing 2-AG tone modulates Significance Sex differences exist within the immune response to infection. However, it is unknown whether sexually dimorphic effects occur in response to activation of the viral TLR3 receptor. This study demonstrates minimal sex-related differences in TLR3-induced acute-phase inflammatory, endocrine, and sickness responses in male and female rats. Furthermore, this study demonstrated that increasing levels of endogenous FAAH substrates, but not 2-AG, attenuate TLR3-induced neuroinflammation in a sex-independent manner. These data highlight FAAH substrates as a potential target for modulating viral TLR3-induced neuroimmune responses, an effect that is applicable to both sexes. TLR3-induced inflammatory responses. Sex differences have been noted in the endocannabinoid system (for review, see Craft, Wakley, Tsutsui, & Laggart, 2012) . For example, male rodents exhibit increased CB 1 receptor density/activity in several brain regions including the hypothalamus, limbic forebrain, hippocampus, and striatum when compared with females (Reich, Taylor, & McCarthy, 2009; Riebe, Hill, Lee, Hillard, & Gorzalka, 2010; Rodriguez de Fonseca Cebeira, Ramos, Martin, & Fernandez-Ruiz, 1994) . In comparison, females exhibit increased CB 1 receptor density in the amygdala when compared with males (Riebe et al., 2010) . Furthermore, increased 2-AG and AEA levels have been reported in the anterior pituitary and hypothalamus of females (Gonzalez et al., 2000) , while another study reported no sex difference in AEA or 2-AG levels in the hypothalamus, thalamus, striatum, hippocampus, or midbrain (Bradshaw, Rimmerman, Krey, & Walker, 2006) . However, it is unknown whether (endo)cannabinoid modulation of TLR-induced immune activation is similar in males and females. Thus, the second aim of this study was to examine the effects of increasing endogenous 2-AG and FAAH substrate levels on acute TLR3-induced inflammatory responses peripherally and centrally and whether sexually dimorphic effects exist. 
| Experimental Design
2.2.1 | Experiment 1: The effect of systemic administration of the TLR3 agonist poly I:C on inflammation, HPA axis activation, and sickness behavior in male and female rats Rats were randomly assigned to one of four treatment groups for both males and females: Saline 4 hr (n 5 6), Saline 8 hr (n 5 6), Poly I:C 4 hr (n 5 9), and Poly I:C 8 hr (n 5 9). The TLR3 agonist poly I:C (3 mg/kg, GE Healthcare, Dublin, Ireland) or saline vehicle (sterile 0.89% NaCl) were administered i.p. in an injection volume of 1.5 ml/kg. The dose and time of poly I:C administration were chosen on the basis of previous published and pilot work in our laboratory demonstrating that systemic administration of poly I:C at this dose increases the expression of inflammatory mediators in both the periphery and the brain over this time period (Henry et al., 2014) . Homecage locomotor activity was assessed during this time using the Opto M3 Dual Axis system (Columbus Instruments, Columbus, OH) as previously described (Bree et al., 2015 (Bree et al., , 2016 . Following decapitation, trunk blood was immediately collected in sterile 15-ml tubes, allowed to clot for at least 1 hr, and then centrifuged at 14,000g for 15 min. Serum was removed and stored in 1-ml aliquots at 2808C until biochemical analysis. In addition, the spleen and hypothalamus were excised, snap-frozen on dry ice, and stored at 2808C until being assayed for inflammatory gene expression.
In a second cohort of animals, rats were randomly assigned to one of four treatment groups: Female-Saline (n 5 11), Female-Poly I:C (n 5 12), Male-Saline (n 5 7), and Male-Poly I:C (n 5 9). Rectal temperature was recorded 0, 4, and 24 hr post poly I:C or saline administration. Body weight was recorded prior to any experimental manipulation and 24 hr post poly I:C administration and used to calculate body weight gain.
| Experiment 2: The effect of systemic administration of the MAGL inhibitor MJN110 on poly I:C-induced inflammatory responses in male and female rats
Male and female rats were randomly assigned to one of three treatment groups: Vehicle-Saline (n 5 4), Vehicle-Poly I:C, and MJN110-poly I:C (n 5 8 per group). The MAGL inhibitor MJN110 (5 mg/kg, gifted from Ben Cravatt Lab) or vehicle (ethanol:cremophor:saline; 1:1:18) was administered i.p. in an injection volume of 2 ml/kg followed 1 hr later by an i.p. injection of poly I:C (3 mg/kg) or saline (sterile 0.89% NaCl) administered in an injection volume of 1.5 mg/kg. The dose of MJN110 was determined on the basis of previous published work ( Niphakis et al., 2013) and pilot work in our lab demonstrating that systemic administration of MJN110 at this dose enhanced levels of 2-AG in the periphery and the brain. Animals were sacrificed by decapitation at 4 hr post poly I:C/saline administration, and then the spleen and hypothalamus were excised, snap-frozen on dry ice, and stored at 2808C until being assayed for endocannabinoid and N-acylethanolamine levels and cytokine expression.
| Experiment 3:
The effect of systemic administration of the FAAH inhibitor URB597 on poly I:C-induced inflammatory responses in male and female rats Male and female rats were randomly assigned to one of three treatment groups: Vehicle-Saline (n 5 4), Vehicle-Poly I:C (n 5 8), and URB597-Poly I:C (n 5 8). The FAAH inhibitor URB597 (1 mg/kg, Cayman Chemicals, Tallin, Estonia) or vehicle (ethanol:cremophor:saline; 1:1:18) was administered i.p. in an injection volume of 2 ml/kg followed 30 min later by an i.p. injection of poly I:C (3 mg/kg) or saline (sterile 0.89% NaCl) administered in an injection volume of 1.5 ml/kg. The dose of URB597 was determined on the basis of previous published work demonstrating that systemic administration of URB597 at this dose enhanced levels of AEA and the related N-acylethanolamines
| 991 (Henry et al., 2014; Kerr et al., 2012) . Animals were sacrificed by decapitation at 4 hr post poly I:C/saline administration, and then the spleen was rapidly removed and the hypothalamus excised, snapfrozen on dry ice, and stored at 2808C until being assayed for levels of endocannabinoids and N-acylethanolamines and cytokine expression.
| Expression of inflammatory mediators assessed using quantitative real-time PCR
RNA was extracted from spleen and hypothalamic tissue using the NucleoSpin RNA II total RNA isolation kit (Macherey-Nagel, Duran, Germany). RNA was reverse transcribed into cDNA using a High Capacity cDNA Archive kit (Applied Biosystems, Cheshire, UK). Taqman gene expression assays (Applied Biosystems, Cheshire, UK) containing forward and reverse primers and a FAM-labeled MGB Taqman probe were used to quantify the gene of interest, and realtime PCR was performed using an ABI Prism 7500 instrument (Applied Biosystems, Cheshire, UK), as previously described (Henry et al., 2014; Kerr et al., 2012 Kerr et al., , 2013 . Assay IDs for the genes were as
PCR was performed using Bioline PCR Master Mix, and samples were run in duplicate. The cycling conditions were 908C for 10 min and 40 cycles of 908C for 15 min followed by 608C for 1 min. b-actin was used as an endogenous control to normalize gene expression data. Relative gene expression was calculated using the DDCT method (Livak & Schmittgen, 2001 ) and expressed as percent change from salinetreated or vehicle-saline-treated groups.
| Estradiol determination
Serum samples were extracted using a liquid-liquid extraction protocol for an accurate determination of total 17b-estradiol levels using a 17b-estradiol high-sensitivity ELISA kit (Enzo Life Sciences, Inc, UK; ADI-901-174). Briefly, diethyl ether was added to the samples at 5:1 v/ v ratio, solutions were mixed by shaking for 2 min, and the phases were allowed to separate for a further 2 min. The organic phase was added to distilled water in a 4:1 v/v ratio, mixed by shaking, and the phases were allowed to separate. The organic phase was evaporated to dryness, and lyophilized samples were reconstituted in 250 ll of assay buffer. The 17b-estradiol assay was then performed according to the manufacturer's instructions. The detection limit of the assay was 14 pg/ml, and the results are expressed as picograms per milliliter of serum.
| Corticosterone determination
Serum corticosterone was assessed as previously described (Roche, Diamond, Kelly, & Finn, 2006 ) using a Corticosterone EIA kit (Cayman Chemicals, Tallin, Estonia; 501320). The assay was carried out in accordance with the manufacturer's instructions. The limit of detection of the assay was 30 pg/ml, and data were expressed as nanograms per milliliter of plasma.
2.6 | Quantification of endocannabinoids and N-acylethanolamine concentrations using liquid chromatography-tandem mass spectrometry Quantification of endocannabinoids and N-acylethanolamines was essentially as described previously (Henry et al., 2014; Kerr et al., 2012 Kerr et al., , 2013 . In brief, samples were homogenized for 5 s in 400 ll 100% acetonitrile containing deuterated internal standards (0.014 nmol AEA-d8, 0.48 nmol 2-AG-d8, 0.016 nmol PEA-d4, 0.015 nmol OEA-d2), centrifuged at 14,000g for 15 min at 48C, and then the supernatant was evaporated to dryness. Lyophilized samples were resuspended in 40 ll 65% acetonitrile and separated on a Zorbax C18 column (50 3 2.1-mm internal diameter, 1.8-lm particle size) by reversed-phase gradient elution initially with a mobile phase of 65% acetonitrile with 0.1% formic acid, which was ramped linearly up to 100% acetonitrile with 0.1% formic acid over 7 min and held at this for a further 5 min (flow rate 200 ll/min). Under these conditions, AEA, 2-AG, PEA, and OEA eluted at the following retention times: 3.5, 4.7, 4.6, and 5.2 min, respectively. 
| Statistical Analysis
Data were analyzed using the SPSS statistical package (IBM SPSS v20.0 for Microsoft Windows; SPSS Inc., Chicago, IL; RRID: SCR_ 002865). Normality was assessed using Shapiro-Wilk test. In experiment 1, three-way ANOVA using sex, treatment, and time as factors revealed no significant effect of sex, and as a result a two-way ANOVA was conducted on male and female gene expression data separately.
Similarly, data obtained for sickness responding and behavior and corticosterone data were analyzed separately for male and female rats using a repeated-measures ANOVA or unpaired t test. In experiments 2 and 3, one-way ANOVA was used to determine differences in gene expression between three groups on male and female data separately as experiments were performed on males and female rats at different times. Unpaired t test was used to analyze differences in endocannabinoid levels. Fisher LSD post hoc test was performed where appropriate. The level of significance was set at p < .05. All graphs were constructed using Graphpad Prism (RRID: SCR_002798), and results are expressed as group mean 6 standard error of the mean. on NFjB-inducible TNF-a expression in both sexes. There was an increase in TNF-a expression in male and female poly I:C-treated groups at both 4 and 8 hr post administration, compared with salinetreated controls (Figure 2d ).
| Poly I:C does not alter estradiol levels, and the poly I:C-induced inflammatory response in female rats is not influenced by estradiol levels
As estradiol has been shown to influence inflammatory responses (Bhatia, Sekhon, & Kaur, 2014), serum estradiol levels were measured in the various groups. As expected, levels of b-estradiol were low in males (78.33 6 12.09 pg/ml) and higher in females (178.17 6 34.06 pg/ml).
There was no significant statistical difference between b-estradiol levels in any of the female groups [F (3,29) 5 0.308, p > .05], indicating that poly I:C does not alter b-estradiol levels. Furthermore, there was no significant effect of b-estradiol levels when included as a cofactor in gene expression analysis in females (p > .05), indicating that b-estradiol levels do not influence the poly I:C-induced acute inflammatory response in female rats in the current study.
3.4 | Poly I:C increases serum corticosterone levels and induces sickness behavior similarly in male and female rats Systemic viral infections are known to induce HPA axis activation and sickness behavior; however, it is unknown whether this response is similar in male and female rodents.
The data herein revealed that serum corticosterone levels, a direct measure of HPA axis activation, were increased 4 hr post poly I:C administration to a similar level in both male and female rats (males: t 11 5 18.166, p < .01; females: t 13 5 6.033, p < .01) (Figure 3a) . t 10 5 3.077, p < .05) (Figure 3c) . Finally, the data revealed that poly I: C-treated male and female animals exhibited a significant decrease in 3.6 | Increasing AEA, OEA, and PEA levels following FAAH inhibition attenuates the poly I:C-induced increase in inflammatory mediator expression in the hypothalamus, but not the spleen, of male and female rats Analysis revealed that URB597 increased AEA [F (2,15) Figure S2) Figure S2) . URB597 did not alter levels of 2-AG in the spleen or hypothalamus of male or female rats (p > .05) (Supplementary Figure S2) . The effects of URB597 on poly I:C-induced increases in IRF7, IP-10, and TNF-a expression in the (a) spleen and (b) hypothalamus of males and females, at 4 hr post administration. Data expressed as mean 6 standard error of the mean (n 5 3-8 per group). ** p < .01 versus vehicle-saline-treated counterparts. 11 p < .01; 1 p < .05; p 5 .064 versus vehicle-poly I:C-treated counterparts FIG URE 4 Poly I:C increased the expression of IRF7, IP-10, and TNF-a in (a) the spleen and (b) the hypothalamus of male and female rats, and these effects were unaltered by MJN110, at 4 hr post poly I:C administration. Data expressed as mean 6 standard error of the mean (n 5 3-8 per group). ** p < .01; *p < .05 versus vehicle-saline-treated counterparts ANOVA revealed that poly I:C increased IRF7 expression in the spleen of both males and females, an effect unaltered by prior systemic administration of URB597 (Figure 5a ). In the hypothalamus, poly I:C induced an increase in IRF7 [males: F (2,19) 5 22.310, p < .01; females: F (2,15) 5 13.207, p < .01]; IP-10 [males: F (2,19) 5 13.811, p < .01; females: F (2,15) 5 40.606, p < .01]; and TNF-a [males:
F (2,19) 5 5.771, p < .05; females: F (2,15) 5 5.020, p < .05] expression in the hypothalamus, which was attenuated by URB597 in both male and female rats (Figure 5b ).
| D I SCUSSION
The present study demonstrated a lack of sex differences in the TLR3-induced expression of either IFN-or NFkB-inducible genes (IFN-a/b, IP-10, or TNF-a) peripherally and centrally (in spleen or hypothalamus), with the exception of a small but significant sex difference for IFN-a expression in the spleen. These TLR3-induced inflammatory effects were associated with increased corticosterone levels, fever, reduced locomotor activity, and body weight-effects independent of sex. A further aspect of this study was to examine whether increasing endocannabinoid (and related N-acylethanolamine) levels modulate the TLR3-induced inflammatory response, and whether such effects were independent of sex. The data herein demonstrated that increasing 2-AG tone, following the systemic administration of the MAGL inhibitor MJN110, did not alter the TLR3-induced inflammatory response in the spleen or hypothalamus of male or female rats. In comparison, systemic administration of the FAAH inhibitor URB597 and associated increases in AEA, OEA, and PEA levels attenuated the TLR3-induced inflammatory response in the hypothalamus, but not the spleen, of both male and female rats. Overall, these findings demonstrate an important role for FAAH substrates in the modulation of TLR3-induced neuroinflammatory responses in both males and females.
The systemic administration of the TLR3 agonist poly I:C has been consistently shown to induce robust increases in peripheral and central inflammatory responses; however, these studies are conducted interchangeably between males (Fortier et al., 2004; Gibney et al., 2013; McLinden et al., 2012) and females (Cunningham et al., 2007; Murray et al., 2015) , with potential sex differences unidentified. The current study demonstrated that systemic poly I:C administration increased the splenic expression of IFN-and NFOEB-related genes (IFN-b, IRF7, IP-10, and TNF-a) in both male and female rats, with maximal expression occurring at 4 hr post administration. These data support clinical studies reporting that IFN-a/b responses (Khan, Summers, Helbert, & Arkwright, 2010; Torcia et al., 2012) and the proinflammatory cytokine IL-6 (Khan et al., 2010) in peripheral blood cells did not differ between men and women in response to TLR3 activation. The only sex-related difference observed in the current study was in IFN-a expression, which was increased in the spleen of female, but not male, rats at 8 hr post poly I:C administration. Although it is unknown whether similar sex-dependent changes occur clinically, IFN-a and/or IFN-b in PBMCs and pDCs from women have been shown to be higher following stimulation of an alternative viral TLR (TLR7) when compared with men (Berghofer et al., 2006; Khan et al., 2010; Meier et al., 2009; Torcia et al., 2012) . Examining TLR3-induced neuroinflammatory responses in the hypothalamus, an important brain region in mediating endocrine and sickness responses to infection, revealed that systemic poly I:C administration increased the expression of IP-10 and TNF-a, at 4 and 8 hr, in both male and female rats. Although there was no significant increase in IFN-a or IFN-b expression in the hypothalamus at either time point examined post poly I:C administration, the increased expression of IP-10 and IRF7 would suggest that type 1 IFNs were produced and active in response to poly I:C administration. Importantly, the poly I:C-induced increases in inflammatory gene expression in the spleen and hypothalamus were independent of serum 17b-estradiol levels in female rats. Although we cannot rule out sex differences in the expression of other genes, the data herein indicate minimal sex-related differences in the early expression of IFN-and NFOEB-related genes peripherally or centrally in response to TLR3 activation.
The activation of central neuroinflammatory responses in the hypothalamus leads to HPA axis activation and increases in corticosterone levels (Gibb, Hayley, Poulter, & Anisman, 2011; Katafuchi et al., 2003; Milton, Hillhouse, & Milton, 1992; Ruzek, Miller, Opal, Pearce, & Biron, 1997) . The current data demonstrated that there were no sex differences in either basal corticosterone levels or the poly I:C-induced increase in corticosterone levels at 4 hr post administration. Previous studies have reported sex differences in basal corticosterone levels, with females exhibiting higher corticosterone levels (Aoki, Shimozuru, Kikusui, Takeuchi, & Mori, 2010; Critchlow, Liebelt, Bar-Sela, Mountcastle, & Lipscomb, 1963; Daneva et al., 1993; Kitay, 1961; Weinstock, Razin, Schorer-Apelbaum, Men, & McCarty, 1998) . However, as the time of blood sampling in this study occurred during the early portion of the light phase instead of during the diurnal elevation in HPA axis activity at the onset of the dark phase, this could explain the lack of sex difference in the data herein and in other studies (Livezey, Miller, & Vogel, 1985; Rivier, 1999) . In addition to HPA axis activation, the current study demonstrates that male and female rats displayed a similar poly I:C-induced fever response at 4 hr, reduced homecage locomotor activity at 4 to 8 hr, and reduced body weight at 24 hr post poly I:C administration. Given the role for IFNs and proinflammatory cytokines in the poly I:C-induced fever response (Bastos-Pereira, Leite, Fraga, & Zampronio, 2015; Fortier et al., 2004) , reduced body weight, and reduced locomotor activity (Murray et al., 2015) , it is likely that these sex-independent effects on TLR3-induced sickness behavior are a result of similar TLR3-induced inflammatory responses in male and female rats.
Several studies have reported that increasing endocannabinoid tone modulates the expression of TLR4-induced inflammatory mediators (for review, see Henry et al., 2016) ; however, there is a paucity of data examining whether similar effects occur following the activation of other TLRs. The current data demonstrate that systemic administration of the MAGL inhibitor MJN110 increased 2-AG levels while the
FAAH inhibitor URB597 increased the levels of AEA, OEA, and PEA in the spleen and hypothalamus of male and female rats. This increase in 2-AG or FAAH substrate levels following systemic administration of MJN110 or URB597, respectively, did not alter the TLR3-induced increase in the expression of the IFN-or NFOEB-inducible genes IRF7, IP-10, and TNF-a in the spleen of male or female rats. In comparison, the increase in FAAH substrates, but not 2-AG, attenuated TLR3-induced neuroinflammatory responses in the hypothalamus in both male and female rodents. It should be noted that although sex differences could not be directly statistically analyzed, the effect of MAGL or FAAH inhibition on TLR3-induced inflammation is similar in both male and female rats, indicating sex-independent effects of these inhibitors under these conditions. Recent work from our group demonstrated that systemic administration of the MAGL inhibitor JZL184 and associated increases in 2-AG levels in the periphery, but not in the brain, attenuated TLR4-induced increases in plasma TNF-a levels and IL-1b, IL-6, TNF-a, and IL-10 expression in the frontal cortex (Kerr et al., 2013) . The current study demonstrated that although the use of the more selective MAGL inhibitor MJN110 (Niphakis et al., 2013) increased 2-AG levels both peripherally and in the brain, this did not alter TLR3-induced neuroinflammatory responses in the hypothalamus.
Although we cannot rule out that effects may be observed in other brain regions, the data suggest that MAGL inhibition and/or 2-AG modulates TLR4-but not TLR3-mediated inflammatory responses. In comparison, the data demonstrate that the inhibition of FAAH resulted in the attenuation of TLR3-induced neuroinflammatory responses in the hypothalamus of male and female rats to a similar level, an effect that occurred in the absence of modulation of peripherally TLR3-induced inflammatory responses. These data corroborate and expand on a recent study from our group demonstrating a role for FAAH substrates in modulation of TLR3-induced neuroinflammatory responses in the hippocampus of male rats (Henry et al., 2014) . However, it should be noted that slight differences are observed between the studies, such as a lack of effect of FAAH inhibition on TLR3-induced IP-10 or IRF7 expression in the hippocampus (Henry et al., 2014) , but attenuation of these genes in the hypothalamus herein. Although the dose of URB597 and poly I:C and the time post injection used in both studies are identical, differences may be due to region under examination. For example, the hypothalamus is less well protected by the blood-brain barrier than other brain regions and thus may be susceptible to exposure to systemic inflammatory mediators or enhanced CNS neuroimmune signaling, which may account for some of the differences in the expression of inflammatory genes post TLR3 activation and effects of URB597 thereon. Furthermore, systemic administration of URB597 increased OEA and PEA, but not AEA, levels in the hippocampus (Henry et al., 2014) , while all 3 FAAH substrates (AEA, OEA, and PEA)
were enhanced in the hypothalamus in the current study. Regardless of these slight differences, the data indicate that systemic administration of the FAAH inhibitor attenuates central, but not peripheral, TLR3-induced inflammatory mediators in both sexes. It should also be noted that similar effects have been observed following direct central FAAH inhibition in the hippocampus (Henry et al., 2014) , and unpublished data from our group have demonstrated that systemic administration of the peripherally restricted FAAH inhibitor URB937 does not alter TLR3-induced expression of inflammatory mediators in the hypothalamus. Taken together, the data indicate that the effects of FAAH inhibition on TLR3-induced inflammatory gene expression are most likely mediated at the level of the brain. Furthermore, we and others have demonstrated that FAAH substrates also potently attenuate TLR4-induced neuroinflammatory responses in several brain regions, including the hypothalamus (Henry et al., 2017; Kerr et al., 2012; Sayd et al., 2014) . Thus, FAAH substrates play an important role in modulating TLR3-(and TLR4-) induced neuroinflammatory responses in both males and females.
In conclusion, the present study demonstrates minimal sex differences in TLR3-induced early inflammatory, endocrine, and sickness responses. In addition, the results herein highlight an important role for FAAH substrates in the modulation of TLR3-induced neuroinflammatory responses in the hypothalamus in both male and female rats, and suggest that these effects are most likely mediated directly at the level of the brain. These data provide further evidence for the therapeutic potential of targeting FAAH for the treatment of disorders with a neuroinflammatory component.
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